Skip to main content
. 2022 Nov 1;15:6413–6422. doi: 10.2147/IDR.S384515

Table 3.

Resistance Rate of Klebsiella pneumoniae to Antibiotics

Antibacterial Drug 2018 n (R)% 2019 n (R)% 2020 n (R)% 2018–2020 n (R)%
n = 70 n = 91 n = 95 n = 256
Piperacillin/tazobactam 42 (60.0) 51 (56.0) 48 (50.5) 141 (55.1)
Ceftazidime 44 (62.9) 61 (67) 51 (53.1) 156 (60.9)
Cefepime 44 (62.9) 52 (57.1) 48 (50.0) 144 (56.3)
Imipenem 34 (48.5) 43 (47.3) 40 (42.1) 117 (45.7)
Bactrim 39 (55.7) 48 (52.7) 48 (50.0) 135 (52.7)
Ciprofloxacin 47 (67.1) 64 (70.3) 60 (62.5) 171 (66.8)
Gentamicin 42 (60.0) 57 (62.6) 59 (61.5) 158 (61.7)
Tobramycin 33 (47.1) 51 (56.0) 50 (52.1) 134 (52.3)
Ampicillin/Sulbactam 49 (70) 66 (72.5) 63 (65.6) 178 (69.5)
Levofloxacin 44 (62.9) 63 (69.2) 57 (59.4) 164 (64.1)
Nitrofurantoin 40 (57.1) 53 (58.2) 55 (57.3) 148 (57.8)
Ampicillin 52 (74.3)
Amikacin 25 (35.7) 35 (38.5) 33 (34.4) 93 (36.3)
Ceftriaxone 50 (71.4) 67 (73.6) 61 (63.5) 178 (69.5)
Cefotetan 31 (44.3) 42 (46.2) 45 (46.9) 118 (46.1)
Ertapenem 0 (0) 0 (0) 0 (0) 0 (0)

Abbreviations: n, number of strains; R, drug resistance rate; “-”, Not detected.